Skip to main content

Advertisement

Log in

Effects of steroids, interferon-2B, or interluekin 1B on apoptosis of fibroblasts from keloid, hypertrophic scars, and normal skin and related signal pathway

  • Original Paper
  • Published:
European Journal of Plastic Surgery Aims and scope Submit manuscript

Abstract

Wound healing can lead to hypertrophic scar or keloid formation, characterized by an overabundant extracellular matrix. Current established treatment strategies include surgical resection, triamcinolone steroid injection, pressure therapy, silicone therapy, radiotherapy, etc. Cytokines also play a critical role in the regulation of cellular activities and extracellular matrix metabolism. Interferons (IFN) represent a group of antifibroproliferative agents that inhibit fibroblast proliferation and collagen production, and interleukin (IL)-1β also accelerates hypertrophic scar fibroblasts to produce collagenolytic enzymes, leading to tissue destruction. This study addressed the effects of steroid, IFN α-2b, or IL-1β on apoptosis and cell pathway of fibroblasts from keloids, hypertrophic scars, and normal skins and different responses of different fibroblasts. Six samples of keloid, six samples of hypertrophic scar, and six samples of normal skin were, respectively, collected from patients, and fibroblasts from different sources were cultured in vitro. After different fibroblasts were treated with dexamethasone (0.1 mg/ml) or IFN α-2b (1,000 μ/ml) or IL-1β (200 μ/ml), Bax and Bcl-2 were detected in situ by immunohistochemical staining; deoxyribonucleic acid ladders of different fibroblasts were observed by gel electrophoresis, and relative activated (phospho-) extracellular-signal-regulated kinase (ERK) 1/2 and c-Jun N-terminal kinase (JNK) pathways were detected by the method of fast activated cell-based enzyme-linked immunosorbent assay. In media containing dexamethasone, apoptosis took place in fibroblasts from keloids, hypertrophic scars, and normal skins by gel electrophoresis with increased rate of Bax/Bcl-2. Activated (phospho-) ERK1/2 and activated (phospho-) JNK expressions increased in three different fibroblasts. In media containing IFN α-2b, no apoptosis took place in three different fibroblasts without any change of expressions of Bax and Bcl-2 except for the expression of decreased Bcl-2 in fibroblasts from keloids. Activated (phospho-) ERK1/2 expression decreased in fibroblasts from keloid and hypertrophic scars without any changes of activated (phospho-) JNK expression, and IFN α-2b did not affect both activated (phospho-) ERK1/2 and activated (phospho-) JNK expressions in fibroblasts from normal skin. In media containing IL-1β, apoptosis of fibroblasts from keloids was induced by stimulating activated (phospho-) ERK1/2 and activated (phospho-) JNK pathways; IL-1β could not induce apoptosis of fibroblasts from normal skin (radio of Bax/Bcl-2 decreasing) whose activated (phospho-) ERK1/2 pathway was stimulated without any changes of activated (phospho-) JNK expression. Apoptosis in fibroblasts from hypertrophic scars was induced by activating the JNK pathway and prohibiting the ERK1/2 pathway. The effects of steroid, IFN α-2b, or IL-1β on apoptosis of different fibroblasts were different through different cell signal pathways, although all of them were effective for treatment of abnormal scars.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

References

  1. Duncan MR, Berman B (1989) Differential regulation of collagen, glycosaminoglycan, fibronectin, and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-alpha and beta and tumor necrosis factor-alpha and beta. J Invest Dermatol 92:699–706

    Article  PubMed  CAS  Google Scholar 

  2. Yoshizaki K, Nishimoto N, Kishimoto T (2002) IL-6 blocking therapy with humanized anti-IL-6 receptor antibody (MRA) in rheumatoid arthritis. Cutting Edge Reports. Available at: http://www.rheuma21st.com (August)

  3. Kovacs EJ (1991) Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 12:17–23

    Article  PubMed  CAS  Google Scholar 

  4. Dasu MR, Hawkins HK, Barrow RE et al (2004) Gene expression profiles from hypertrophic scar fibroblasts before and after IL-6 stimulation. J Pathol 202:476

    Article  PubMed  CAS  Google Scholar 

  5. Luo S, Benathan M, Raffoul W et al (2001) Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg 107:87–96

    Article  PubMed  CAS  Google Scholar 

  6. Appleton I, Brown NJ, Willoughby DA (1996) Apoptosis, necrosis, and proliferation: Possible implications in the etiology of keloids. Am J Pathol 149:1441–1447

    PubMed  CAS  Google Scholar 

  7. Desmouliere A, Redard M, Darby I et al (1995) Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146:56–66

    PubMed  CAS  Google Scholar 

  8. Sayah DN, Soo C, Shaw WW et al (1999) Downregulation of apoptosis-related genes in keloid tissues. J Surg Res 87:209–216

    Article  PubMed  CAS  Google Scholar 

  9. Green DR, Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science 305:626–629

    Article  PubMed  CAS  Google Scholar 

  10. Cory S, Huang DC, Adams JM (2003) The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22:8590–8607

    Article  PubMed  CAS  Google Scholar 

  11. Kirkin V, Joos S, Zornig M (2004) The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta 1644:229–249

    Article  PubMed  CAS  Google Scholar 

  12. Yang SH, Chien CM, Lu MC et al (2006) Up-regulation of Bax and endonuclease G, and down-modulation of Bcl-XL involved in cardiotoxin III-induced apoptosis in K562 cells. Exp Mol Med 38:435–444

    PubMed  CAS  Google Scholar 

  13. Adams JM, Harris AW, Strasser A et al (1999) Transgenic models of lymphoid neoplasia and development of a panhematopoietic vector. Oncogene 18:5268–5277

    Article  PubMed  CAS  Google Scholar 

  14. Oltvai ZN, Milliman CL, Lorsmeger SJ (1993) Bcl-2heterdimerizes in vivo with a conserved homology, Bax, that accelerates programmed cell death. Cell 74:609–621

    Article  PubMed  CAS  Google Scholar 

  15. Ballif BA, Blenis J (2001) Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)–MAPK cell survival signals. Cell Growth Differ 12:397–408

    PubMed  CAS  Google Scholar 

  16. Pearson G, Robinson F, Beers Gibson T et al (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153–183

    Article  PubMed  CAS  Google Scholar 

  17. Finlay GA, Thannickal VJ, Fanburg BL et al (2000) Transforming growth factor-. b. 1-induced activation of the ERK pathway/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor. J Biol Chem 275:27650–27656

    PubMed  CAS  Google Scholar 

  18. Xia Z, Dickens M, Raingeaud J et al (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326–1331

    Article  PubMed  CAS  Google Scholar 

  19. Fettucciari K, Fetriconi I, Bartoli A et al (2003) Involvement of mitogen-activated protein kinases in Group B Streptococcus-induced macrophage apoptosis. Pharmacol Res 47:355–362

    Article  PubMed  CAS  Google Scholar 

  20. Daian T, Ohtsuru A, Rogounovitch T et al (2003) Insulinlike growth factor-I enhances transforming growth factor-induced extracellular matrix protein production through the p38/activating transcription factor-2 signaling pathway in keloid fibroblasts. J Invest Dermatol 120:956–962

    Article  PubMed  CAS  Google Scholar 

  21. Gupta K, Kshirsagar S, Li W et al (1999) VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp Cell Res 247:495–504

    Article  PubMed  CAS  Google Scholar 

  22. Widmann C, Gibson S, Jarpe MB et al (1999) Mitogen-activated protein kinase. Conservation of a three-kinase module from yeast to human. Physiol Rev 79:143–180

    PubMed  CAS  Google Scholar 

  23. Cobb MH, Boulton TG, Robbins DJ (1991) Extracellular signal-regulated kinase: ERKs in progress. Cell Regul 2:965–978

    PubMed  CAS  Google Scholar 

  24. Thomas G (1992) MAPkinase by any other name smells just as sweet. Cell 68:3–6

    Article  PubMed  CAS  Google Scholar 

  25. Burgering BM, de Vries-Smits AM, Medema RH et al (1993) Epidermal growth factor induces phosphorylation of extracellular signal-regulated kinase 2 via multiple pathways. Mol Cell Biol 13:7248–7256

    PubMed  CAS  Google Scholar 

  26. Szabowski A, Maas-Szabowski N, Andrecht S et al (2000) c-Jun and JunB antagonistically control cytokine-regulated mesenchymal–epidemal interaction in skin. Cell 103:745–755

    Article  PubMed  CAS  Google Scholar 

  27. Liu ZG, Hsu H, Goeddel DV et al (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87:565–576

    Article  PubMed  CAS  Google Scholar 

  28. Yujiri T, Sather S, Fanger GR et al (1998) Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science 282:1911–1914

    Article  PubMed  CAS  Google Scholar 

  29. Kauh YC, Rouda S, Mondragon G et al (1997) Major suppression of pro-alpha1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol 37:586–589

    Article  PubMed  CAS  Google Scholar 

  30. Poochareon VN, Berman B (2003) New therapies for the management of keloids. J Craniofacial Surg 14:654–657

    Article  Google Scholar 

  31. Harrop AR, Ghahary A, Scott PG et al (1995) Regulation of collagen synthesis and mRNA expression in normal and hypertrophic scar fibroblasts in vitro by interferon-g. J Surg Res 58:471–477

    Article  PubMed  CAS  Google Scholar 

  32. Duncan MR, Berman B (1989) Differential regulation of glycosaminoglycan, fibronectin, and collagenase production in cultured human dermal fibroblasts by interferon-α, -β, and -γ. Arch Dermatol Res 281:11–18

    Article  PubMed  CAS  Google Scholar 

  33. Tamai K, Ishikawa H, Mauviel A et al (1995) Interferon-g coordinately upregulates matrix metalloproteinase (MMP)-1 and MMP-3, but not tissue inhibitor of metalloproteinases (TIMP), expression in cultured keratinocytes. J Invest Dermatol 104:384–390

    Article  PubMed  CAS  Google Scholar 

  34. Gurujey Alakshmi G, Giri SN (1995) Molecular mechanisms of antifibrotic effect of interferon-. g. in bleomycinmouse model of lung fibrosis: down regulation of TGF-. b. and procollagen I and III gene expression. Exp Lung Res 21:791–808

    Article  CAS  Google Scholar 

  35. Duncan MR, Hasan A, Berman B (1995) Pentoxifylline, pentifylline, and interferons decrease type I and III procollagen mRNA levels in dermal fibroblasts: evidence for mediation by nuclear factor 1 down-regulation. J Invest Dermatol 104:282–286

    Article  PubMed  CAS  Google Scholar 

  36. Tredget ET, Wang RJ, Shen Q et al (2000) Transforming growth factor-. b. mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-. a. and IFN-. g. in vitro and in vivo. J Interferon Cytokine Res 20:143–151

    Article  PubMed  CAS  Google Scholar 

  37. Gailit J, Clark RA (1994) Wound repair in the context of extracellular matrix. Curr Opin Cell Biol 6:717–725

    Article  PubMed  CAS  Google Scholar 

  38. McPherson JM, Piez KA (1996) Collagen in dermal wound repair. In: Clark RAF (ed) The molecular and cell biology of wound repair. Plenum, New York, pp 471–496

    Google Scholar 

  39. Rockwell WB, Cohen IK, Ehrlich HP (1989) Keloids and hypertrophic scars: a comprehensive review. Plast Reconstr Surg 84:827–837

    Article  PubMed  CAS  Google Scholar 

  40. Barbul A (1990) Immune aspects of wound repair. Clin Plast Surg 17:433–442

    PubMed  CAS  Google Scholar 

  41. Barrow RE, Dasu MR (2005) Oxidative and heat stress gene changes in hypertrophic scar fibroblasts stimulated with Interleukin-1. b. J Surg Res 126:59–65

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This work was supported by grants from the Hangzhou Normal University Foundation and Education Department of Zhejiang Province. We are grateful to Xielai Zhou M.D. and Professor Li Sun M.D. from Hangzhou Normal University, for advice on the manuscript and help on statistical analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shaojun Xu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xu, S., Li, D., Teng, J. et al. Effects of steroids, interferon-2B, or interluekin 1B on apoptosis of fibroblasts from keloid, hypertrophic scars, and normal skin and related signal pathway. Eur J Plast Surg 30, 159–167 (2007). https://doi.org/10.1007/s00238-007-0165-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00238-007-0165-3

Keywords

Navigation